|
ZNF419 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.08609999882603E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.5057954882991E-11 |
| Normal-vs-Stage2 |
2.933700E-02 |
| Normal-vs-Stage3 |
2.096400E-02 |
| Normal-vs-Stage4 |
1.186250E-01 |
| Stage1-vs-Stage2 |
1.006590E-01 |
| Stage1-vs-Stage3 |
2.435800E-02 |
| Stage1-vs-Stage4 |
2.460000E-03 |
| Stage2-vs-Stage3 |
8.107600E-01 |
| Stage2-vs-Stage4 |
4.302200E-01 |
| Stage3-vs-Stage4 |
5.606000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.07550000022694E-07 |
| Normal-vs-AfricanAmerican |
1.59468999999524E-05 |
| Normal-vs-Asian |
1.552390E-01 |
| Caucasian-vs-AfricanAmerican |
2.383600E-02 |
| Caucasian-vs-Asian |
2.932600E-01 |
| AfricanAmerican-vs-Asian |
8.877600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89949999995775E-06 |
| Normal-vs-Female |
3.75219999515508E-08 |
| Male-vs-Female |
3.319200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.561300E-03 |
| Normal-vs-Age(41-60Yrs) |
6.65569999114268E-09 |
| Normal-vs-Age(61-80Yrs) |
4.175600E-04 |
| Normal-vs-Age(81-100Yrs) |
1.897220E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.486400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.311580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.929410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.500220E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.457800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.319600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.837400E-04 |
| Normal-vs-Grade 2 |
2.06059613816478E-11 |
| Normal-vs-Grade 3 |
1.359580E-03 |
| Normal-vs-Grade 4 |
6.926000E-01 |
| Grade 1-vs-Grade 2 |
6.810300E-02 |
| Grade 1-vs-Grade 3 |
3.602400E-03 |
| Grade 1-vs-Grade 4 |
4.581100E-04 |
| Grade 2-vs-Grade 3 |
1.718480E-03 |
| Grade 2-vs-Grade 4 |
6.30459999999555E-05 |
| Grade 3-vs-Grade 4 |
8.263600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.76090039719179E-10 |
| Normal-vs-ccB subtype |
7.161500E-03 |
| ccA subtype-vs-ccB subtype |
2.161600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68818999999321E-05 |
| Normal-vs-N1 |
8.265600E-01 |
| N0-vs-N1 |
2.540200E-01 |
|
|
